Skip to content

ICU Medical ICUI AOCI - Cash Flow Hedge Adjustment

AOCI - Cash Flow Hedge Adjustment at other companies

Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's aoci - cash flow hedge adjustment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's AOCI - cash flow hedge adjustment?
ICU Medical (ICUI) reported AOCI - cash flow hedge adjustment of -$6.55M in Q1 2026.
How has ICU Medical's AOCI - cash flow hedge adjustment changed year-over-year?
ICU Medical's AOCI - cash flow hedge adjustment decreased by 3945.7% year-over-year, from -$162K to -$6.55M.
What is the long-term trend for ICU Medical's AOCI - cash flow hedge adjustment?
Over 2 years (2023 to 2025), ICU Medical's AOCI - cash flow hedge adjustment has grown at a -34.2% compound annual growth rate (CAGR), from $21.88M to -$9.48M.